Publikationen, an denen er mitarbeitet Josep Francesc Nomdedéu Guinot (8)

2020

  1. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    Blood, Vol. 135, Núm. 5, pp. 371-380

  2. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: A subanalysis from the RATIFY trial

    Blood Advances, Vol. 4, Núm. 19, pp. 4945-4954

2019

  1. An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

    Leukemia and Lymphoma, Vol. 60, Núm. 4, pp. 1030-1035

2018

  1. Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia

    Cancers, Vol. 10, Núm. 11

2017

  1. NEDD 9 an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients

    Oncotarget, Vol. 8, Núm. 44, pp. 76003-76014

2004

  1. Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial

    Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092

2001

  1. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes

    Leukemia and Lymphoma, Vol. 42, Núm. 4, pp. 747-756

  2. Systemic mast cell disease associated with B-chronic lymphocytic leukemia

    Haematologica, Vol. 86, Núm. 10, pp. 1106-1107